Monitoring of a multi-modal schedule for the treatment of disseminated breast cancer.
39 women and 1 man have been monitored by sequential CEA, immunoglobulin, lymphocyte and monocyte readings, hydroxyproline excretion, scans and x-rays. CEA is shown to be a useful monitor of disease. The significance of the lymphocyte counts is discussed.